Physician profile
Christopher Bateman Dewing
NPI 1477608875
$3,263.44
in general payments reported to CMS, 2019-2025
10 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,109 · 2020: $21.47 · 2021: $1,232 · 2022: $258 · 2023: $240 · 2024: $107 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $1,411.36 | 2019-2023 | |
| Arthrex, INC. | $1,010.12 | 2019-2024 | |
| Sawtooth Surgical Solutions INC | $290.23 | 2024-2025 | |
| Smith+Nephew, INC. | $188.58 | 2020-2022 | |
| Stryker Corporation | $143.07 | 2021-2024 | Salvation, Omega, Hipcheck |
| Vericel Corporation | $130.42 | 2022-2025 | Maci |
| Novo Nordisk INC | $33.82 | 2021-2023 | Wegovy |
| Depuy Synthes Sales INC. | $22.81 | 2023 | Speedtrap, Truespan Orthocord |
| Djo, LLC | $19.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.